BREAKTHROUGHS BLOG

April 17, 2014

Research Roundup: What we’re reading this week

Senior Program Assistant
GHTC

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

The European Parliament approved the European Union’s participation in the second round of the European & Developing Countries Clinical Trials Partnership (EDCTP). EDCTP’s activities will include promoting and supporting multicenter projects that combine clinical trials, capacity building, and networking; capacity development for clinical trials and clinical research in sub-Saharan countries; and closer collaboration with industry, other product development partners, and funding or development agencies.

According to an opinion piece in Proceedings of the National Academy of Sciences, some scientists warn that US biomedical research is on an unsustainable path and needs reform. The scientists suggest that the system may be producing too many new researchers and forcing them to compete for a stagnating pool of funding.

GHTC member the Global Health Innovation and Technology (GHIT) Fund was recently interviewed by Devex. In the interview, GHIT Fund executive director, B.T. Slingsby, spoke about what support is needed for research and development to continue the fight against malaria and tuberculosis, and how public-private partnerships can help put these overlooked diseases back on the map.

A team of researchers at the Indian Institute of Science have been experimenting with a novel vaccine candidate against malaria and have found promising results in mice. The vaccine candidate has been proven to be 80 to 85 percent efficacious in the animals recently vaccinated.

Posted in:
back